Aeterna Zentaris (TSE:AEZS) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aeterna Zentaris Inc., a biopharmaceutical firm, is requesting a court order to delay its annual shareholder meeting until July 31, 2024, to finalize its merger with Ceapro Inc. This extension is meant to allow Ceapro’s former shareholders to participate in key votes at the meeting. Additionally, the company has confirmed June 3, 2024, as the redemption date for due bills from a recent warrant issuance.
For further insights into TSE:AEZS stock, check out TipRanks’ Stock Analysis page.